Paul Edwards joins the Board of OBN as a Non-Executive Director

Paul has over 40 years’ experience in the pharmaceutical and life science arena. A graduate chemist, he initially worked for Beecham Pharmaceuticals and Genzyme Corporation, where he headed the UK operations for the company. In 2000, he joined the UK based biosimilars’ organisation, GeneMedix plc as Chief Executive Officer, and successfully led a major funding round taking the company to a dual listing on the London and Singapore Stock Exchanges. More recently, Paul has acted as a NED to Goldshield Group plc and BioProducts Laboratories and oversaw the sale of both organisations to Private Equity Groups. He acted as interim CEO to NanoMab Technology Ltd as well as serving as Managing Partner and board member of the global Executive Search Group, Horton International. Paul is a familiar face in the UK biotech arena, having been the Chairman of the UK BioIndustry Association’s Manufacturing Advisory Committee and was the recipient of the Donald Medal for services to Biochemical Engineering (1999). In 1997 he received an MBE for services to biotechnology. Paul joined the OBN Board in March 2021.

Stay Connected

More News...

Alina Dulija Joins Us

The SCi Partners team has been further augmented by the arrival of Alina Dulija as Senior Researcher. Alina is a multi-lingual life science researcher who

Read More...

REAP Conference 2022

Dafydd Wright and Tarquin Bennett-Coles delved into innovation in agriculture at last week’s Agri-TechE conference REAP. Agriculture is deep into the digital revolution with advanced

Read More...

CPHI Frankfurt

Bethany Latham, Researcher and Austin Clark, Group Operations from SCi Partners represented us at CPHI Frankfurt 1-3 November. The event was an exceptionally dynamic exhibition

Read More...